Search results for " vein."

showing 10 items of 690 documents

Trends in mortality related to pulmonary embolism in the European Region, 2000-15: analysis of vital registration data from the WHO Mortality Database

2020

Summary Background European estimates of the burden imposed by pulmonary embolism are not available to this date. We aimed to assess pulmonary embolism-related mortality and time trends in the WHO European Region. Methods We analysed vital registration data from the WHO Mortality Database (2000–15) covering subregions of the WHO European Region: Eastern Europe, Northern Europe, Southern Europe, Western Europe, and Central Asia. Deaths were considered pulmonary embolism-related if International Classification of Disease-10 code for acute pulmonary embolism (I26) or any code for deep or superficial vein thrombosis was listed as the primary cause of death. We used locally estimated scatterplot…

AdultMalePulmonary and Respiratory MedicineAdolescentDatabases FactualSuperficial vein thrombosisPopulation610 Medicine & healthWorld Health Organizationcomputer.software_genreYoung AdultCase fatality rateHumansMedicineeducationAgedCause of deathAged 80 and overeducation.field_of_studyDatabasebusiness.industryIncidenceIncidence (epidemiology)Mortality rate10031 Clinic for AngiologyMiddle Agedmedicine.diseasePulmonary embolismEurope2740 Pulmonary and Respiratory MedicineAsia CentralFemalePulmonary EmbolismbusinesscomputerCohort study
researchProduct

Infrequent early recanalization of greater saphenous vein after endovenous laser treatment

2003

Abstract Objective The frequency of recanalization of the greater saphenous vein (GSV) after endovenous laser treatment (ELT) is unclear. This study was undertaken to establish the incidence of early recanalization after ELT and to study the histopathologic features of reperfused and excised GSV. Methods One hundred nine GSV in 85 consecutive patients with clinical stage C 2-6 E P,S A S,P,D P R disease were treated with ELT. Twelve months of follow-up with duplex scanning at regular intervals was possible in 104 treated veins (95.4%) in 82 patients (96.5%). Recanalized vessels were removed surgically and examined at histopathology. Results ELT-induced occlusion proved permanent at duplex sc…

AdultMaleReoperationmedicine.medical_specialtyHigh ligationAdolescentmedicine.medical_treatmentGreater saphenous veinRisk AssessmentSeverity of Illness IndexCohort StudiesDuplex scanningOcclusionmedicineHumansSaphenous VeinProspective StudiesStage (cooking)Vascular PatencyAgedAged 80 and overUltrasonography Doppler Duplexbusiness.industryBiopsy NeedleEndovenous laser treatmentMiddle AgedImmunohistochemistrySurgeryTreatment OutcomeLower ExtremityVenous InsufficiencyFemaleSurgeryHistopathologyLaser TherapyCardiology and Cardiovascular MedicinebusinessSaphenous veinsFollow-Up StudiesJournal of Vascular Surgery
researchProduct

Thromboembolic events in Fabry disease and the impact of factor V Leiden

2015

Although several reports suggest an increased thromboembolic event rate, especially regarding strokes and TIAs at early age in patients with Fabry disease (FD), the risk for patients with FD to experience these events, the clinical relevance of additional risk factors including the concurrence of factor V Leiden (FVL), and the benefit of enzyme replacement therapy (ERT) regarding these events remain unclear.Three hundred four consecutively recruited patients with FD were evaluated for their lifetime occurrence of thromboembolic events such as stroke, TIA, deep vein thrombosis, and pulmonary embolism. The thromboembolic risk was determined in patients with FD and concurrent FVL, and the impa…

AdultMaleRiskmedicine.medical_specialtyAdolescentEndocrinology Diabetes and MetabolismDeep veinComorbidityBiochemistryYoung AdultEndocrinologyInternal medicineGeneticsmedicineFactor V LeidenHumansEnzyme Replacement TherapyChildMolecular BiologyStrokeAgedAged 80 and overVenous Thrombosisbusiness.industryHazard ratioFactor VEnzyme replacement therapyMiddle Agedmedicine.diseaseFabry diseaseThrombosisComorbidityPulmonary embolismStrokemedicine.anatomical_structureIschemic Attack TransientChild PreschoolFabry DiseaseFemaleNeurology (clinical)Pulmonary EmbolismbusinessNeurology
researchProduct

Natural history of mesenteric venous thrombosis in patients treated with vitamin K antagonists: a multi-centre, retrospective cohort study.

2009

summaryKnowledge on the natural history of mesenteric vein thrombosis (MVT) and of the efficacy and safety of long-term oral anticoagulant therapy (OAT) in this setting is based on small uncontrolled series of patients with a limited follow-up. It was the aim of the study to assess the natural history of MVT in a cohort of patients treated with OAT. The charts of all MVT patients currently attending or who have attended four anticoagulation clinics were reviewed. Information on risk factors, treatment, recurrence, major bleeding and mortality was collected. Seventyseven patients (mean age 49.2 years; 45 males) were included with a median follow-up of 36 months (range 2–204 months). Forty-si…

AdultMaleRiskmedicine.medical_specialtyVitamin Kmedicine.drug_classmedicine.medical_treatmentSettore MED/15 - Malattie Del SangueCohort StudiesRisk FactorsmedicineHumansVeinAgedRetrospective StudiesAged 80 and overVenous ThrombosisChemotherapybusiness.industryAnticoagulantAnticoagulantsRetrospective cohort studyHematologyMiddle Agedmedicine.diseaseSurgeryMesenteric ArteriesNatural historyVenous thrombosismedicine.anatomical_structuremesenteric vein thrombosisCohortFemalebusinessCohort study
researchProduct

Digital image analysis of liver collagen predicts clinical outcome of recurrent hepatitis C virus 1 year after liver transplantation.

2011

Clinical outcomes of recurrent hepatitis C virus after liver transplantation are difficult to predict. We evaluated collagen proportionate area (CPA), a quantitative histological index, at 1 year with respect to the first episode of clinical decompensation. Patients with biopsies at 1 year after liver transplantation were evaluated by Ishak stage/grade, and biopsy samples stained with Sirius red for digital image analysis were evaluated for CPA. Cox regression was used to evaluate variables associated with first appearance of clinical decompensation. Receiver operating characteristic (ROC) curves were also used. A total of 135 patients with median follow-up of 76 months were evaluated. At 1…

AdultMaleTime FactorsAdolescentBiopsyHepatic Veins/physiopathologyKaplan-Meier EstimateLiver Cirrhosis/metabolism/pathology/physiopathology/*surgery/virologyRisk AssessmentSensitivity and Specificity*Image Interpretation Computer-AssistedYoung AdultPredictive Value of TestsRecurrenceRisk FactorsLondonHumansLiver/blood supply/*metabolism/pathology/*surgery/virologyChildAgedProportional Hazards ModelsRetrospective Studiesliver transplantationLiver Transplantation/*adverse effectsMiddle AgedROC CurveCollagen/*metabolismFemaleHepatitis C/complications/metabolism/pathology/physiopathology/*surgeryEnd Stage Liver Disease/pathology/physiopathology/*surgery/virologyVenous Pressure
researchProduct

Neutrophil‐mediated enhancement of angiogenesis and osteogenesis in a novel triple cell co‐culture model with endothelial cells and osteoblasts

2017

Repair and regeneration of critical‐sized bone defects remain a major challenge in orthopaedic and craniomaxillofacial surgery. Until now, attempts to bioengineer bone tissue have been hindered by the inability to establish proper angiogenesis and osteogenesis in the tissue construct. In the present study, we established a novel triple cell co‐culture model consisting of osteoblasts, endothelial cells, and neutrophils and conducted a systematic investigation of the effects of neutrophils on angiogenesis and osteogenesis. Neutrophils significantly increased angiogenesis in the tissue construct, evidenced by the formation of microvessel‐like structures with an extensive lattice‐like, stable t…

AdultMaleVascular Endothelial Growth Factor A0301 basic medicineTime FactorsNeutrophilsAngiogenesis0206 medical engineeringCellBiomedical EngineeringBone MatrixNeovascularization PhysiologicMedicine (miscellaneous)02 engineering and technologyMatrix metalloproteinaseBone tissueBone morphogenetic protein 2BiomaterialsYoung Adult03 medical and health sciencesCalcification PhysiologicTissue engineeringOsteogenesisHuman Umbilical Vein Endothelial CellsmedicineHumansViability assayCell ShapeBone growthOsteoblastsChemistryTransendothelial and Transepithelial Migration:Chemical engineering [Engineering]Middle Aged020601 biomedical engineeringCoculture TechniquesCell biology030104 developmental biologymedicine.anatomical_structureGene Expression RegulationFemaleAngiogenesisBiomarkersBiomedical engineeringJournal of Tissue Engineering and Regenerative Medicine
researchProduct

Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES): six-month results of a prospective randomized clinical trial

2014

Purpose To compare standard-of-care grid laser photocoagulation versus intravitreal ranibizumab (IVR) versus a combination of both in the treatment of chronic (>3 months) macular oedema secondary to branch retinal vein occlusion. Methods Prospective, randomized, multicentre clinical trial. Thirty patients with a best-corrected visual acuity (BCVA) between 20/320 and 20/40 were randomized 1:1:1 to receive grid laser or three monthly injections of 0.5 mg IVR or both followed by 3 months of observation. Results Mean change from baseline BCVA at month 6 was +2 letters [laser; 0.04 logMAR, 95% confidence interval (−0.17; 0.25)], +17 letters [IVR; 0.34 (0.19; 0.5)] and +6 letters [combination; 0.…

AdultMaleVascular Endothelial Growth Factor Amedicine.medical_specialtyVisual acuitygenetic structuresVisual AcuityAngiogenesis InhibitorsAntibodies Monoclonal HumanizedMacular Edemalaw.invention03 medical and health scienceschemistry.chemical_compound0302 clinical medicineRandomized controlled trialRecurrencelawRanibizumabOphthalmologyRetinal Vein OcclusionHumansMedicineProspective Studies030212 general & internal medicineMacular edemaAgedAged 80 and overLaser Coagulationbusiness.industryRetinalGeneral MedicineMiddle Agedmedicine.diseaseCombined Modality TherapyConfidence interval3. Good healthSurgeryClinical trialOphthalmologychemistryIntravitreal Injections030221 ophthalmology & optometryBranch retinal vein occlusionFemaleLasers SemiconductorRanibizumabmedicine.symptombusinessmedicine.drugActa Ophthalmologica
researchProduct

Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behcet's disease and deep vein thrombosis

2004

OBJECTIVE: To evaluate the frequency and type of vascular lesions and to study the association of factor V gene G1691A (Leiden) and prothrombin gene G20210A polymorphisms with venous thrombosis in Italian patients with Behçet's disease (BD). METHODS: Included were 118 consecutive Italian BD patients followed over a 3-year period (1997-1999) who satisfied the International Study Group criteria for BD. The control group consisted of 132 healthy Italian blood donors. All BD patients and controls were genotyped by polymerase chain reaction and allele-specific restriction enzyme techniques for factor V Leiden and prothrombin gene G20210A polymorphisms. RESULTS: Vascular lesions were observed in …

AdultMaleVenous ThrombosisFactor V Leiden mutation Prothrombin G20210A mutationAdolescentGenotypeBehcet SyndromeFactor VMiddle AgedBehc ̧et’s disease; Deep vein thrombosis; Factor V Leiden mutation Prothrombin G20210A mutationAdolescent; Adult; Behcet Syndrome; Factor V; Female; Gene Frequency; Genotype; Humans; Italy; Male; Middle Aged; Prothrombin; Risk Factors; Venous Thrombosis; Point MutationGene FrequencyItalyDeep vein thrombosiRisk FactorsFactor V Leiden mutationHumansPoint MutationFemaleProthrombinProthrombin G20210A mutationBehcet’s disease
researchProduct

Transient hepatic nodular lesions associated with patent ductus venosus in preterm infants.

2010

We report on two cases of low-birth-weight preterm infants with patent ductus venosus associated with hepatic hypoechoic lesions of the fourth segment in an otherwise normal liver. Although tumorlike hepatic lesions have been previously reported in association with portosystemic shunts in children and adults, they were never described in preterm infants during physiological patency of ductus venosus. In our patients, hepatic lesions disappeared shortly after the spontaneous ductus closure. Physiopathologic interactions are discussed regarding altered portal blood supply caused by ductus venosus shunt.

AdultMalecongenital hereditary and neonatal diseases and abnormalitiesmedicine.medical_specialtyGestational AgeHepatic VeinsSettore MED/38 - Pediatria Generale E SpecialisticaInternal medicinemedicineHumanscardiovascular diseasesUltrasonographyPATENT DUCTUS VENOSUSbusiness.industryFocal nodular hyperplasiaInfant NewbornPortosystemic shunt - focal nodular hyperplasia - focal fatty sparing - ultrasoundObstetrics and GynecologyInfant Low Birth Weightmedicine.diseaseSurgeryPortal SystemLiverNodular lesionsFocal Nodular HyperplasiaPediatrics Perinatology and Child HealthPortal bloodcardiovascular systemCardiologyFemalePortosystemic shuntbusinessShunt (electrical)Ductus venosusInfant PrematureLiver CirculationAmerican journal of perinatology
researchProduct

Focal nodular hyperplasia-like lesions in patients with cavernous transformation of the portal vein: prevalence, MR findings and natural history.

2011

PURPOSE: To retrospectively investigate the prevalence, MR findings, natural history, and association with other hepatic lesions of focal nodular hyperplasia (FNH)-like lesions in a cohort of consecutive patients with cavernous transformation of the portal vein (CTPV). MATERIALS AND METHODS: This retrospective IRB-approved study comprised 58 patients (32 men, 26 women; average age, 50 years) with CTPV who underwent liver MR imaging between 2000 and 2008. MR images were assessed by two radiologists in consensus for the presence of (a) FNH-like lesions and other liver lesions, and (b) other imaging findings. Patients were assigned to a stable or progressive clinical course based on lesion cha…

AdultMalemedicine.medical_specialtyAbdomen Liver Cavernous transformation of the portal vein Benign liver neoplasms Magnetic resonance imagingAdenomaLesionHemangiomaCohort StudiesReference ValuesmedicineImage Processing Computer-AssistedHumansRadiology Nuclear Medicine and imagingLiver focal nodular hyperplasia cavernomatosis portal veinNeuroradiologyAgedRetrospective Studiesmedicine.diagnostic_testbusiness.industryPortal VeinLiver NeoplasmsFocal nodular hyperplasiaMagnetic resonance imagingInterventional radiologyGeneral MedicineMiddle Agedmedicine.diseaseMagnetic Resonance Imagingmedicine.anatomical_structureTreatment OutcomeFocal Nodular HyperplasiaAbdomenFemaleRadiologymedicine.symptombusinessSettore MED/36 - Diagnostica Per Immagini E RadioterapiaEuropean radiology
researchProduct